News and Announcements
Savvy dad’s app that helps kids earn screen time by doing house work
- Published July 05, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Story by 7NEWS Sunshine Coast:
Mowing the lawn for pocket money just doesn’t cut it with today’s kids, so one savvy dad came up with the idea of household chores in exchange for screen time.
The light bulb moment has just earned him a million dollars in government backing for an app.
Click here to watch the 7NEWS segment.
About ScreenCoach
ScreenCoach manages kids screen time and helps get kids more active, do their homework and help out more around the home.
ScreenCoach is a SaaS product that uses hardware and software to help solve a global problem.
ScreenCoach is a world first gamified electronic rewards system where kids can earn time (or pocket money) on their devices from the chores, tasks and movement they do around the home.
In 2020 we secured the Accelerating Commercialisation grant for $330,0000 which enabled us to complete Alpha trials around Australia. We move to Beta trials in July 2021 and ‘Go Live’ at the end of this year.
We have built our technology to scale rapidly with plans for Global expansion in 2022.
We are still an ESIC compliant company, granting investors a 20% tax rebate and capital gains tax exemption on their investment.
Our goal is to create a highly profitable company which reduces stress for parents, teaches kids how to self manage their screen time, improve parent-child connection and boost harmony in homes all over the world.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
